BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10700392)

  • 1. Inhibition of bacterial peptide deformylase by biaryl acid analogs.
    Green BG; Toney JH; Kozarich JW; Grant SK
    Arch Biochem Biophys; 2000 Mar; 375(2):355-8. PubMed ID: 10700392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
    Grant SK; Green BG; Kozarich JW
    Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification, characterization, and inhibition of peptide deformylase from Escherichia coli.
    Rajagopalan PT; Datta A; Pei D
    Biochemistry; 1997 Nov; 36(45):13910-8. PubMed ID: 9374870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the design of antibiotics targeting peptide deformylase.
    Hao B; Gong W; Rajagopalan PT; Zhou Y; Pei D; Chan MK
    Biochemistry; 1999 Apr; 38(15):4712-9. PubMed ID: 10200158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial Peptide Deformylase Inhibition of Tetrazole-Substituted Biaryl Acid Analogs: Synthesis, Biological Evaluations, and Molecular Docking Study.
    Khan FA; Patil RH; Patil M; Arote R; Shinde DB; Sangshetti JN
    Arch Pharm (Weinheim); 2016 Dec; 349(12):934-943. PubMed ID: 27859538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial activity of peptide deformylase inhibitors.
    Huntington KM; Yi T; Wei Y; Pei D
    Biochemistry; 2000 Apr; 39(15):4543-51. PubMed ID: 10758004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A direct spectrophotometric assay for peptide deformylase.
    Guo XC; Ravi Rajagopalan PT; Pei D
    Anal Biochem; 1999 Sep; 273(2):298-304. PubMed ID: 10469501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-beta-lactamase.
    Toney JH; Fitzgerald PM; Grover-Sharma N; Olson SH; May WJ; Sundelof JG; Vanderwall DE; Cleary KA; Grant SK; Wu JK; Kozarich JW; Pompliano DL; Hammond GG
    Chem Biol; 1998 Apr; 5(4):185-96. PubMed ID: 9545432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide aldehyde inhibitors of bacterial peptide deformylases.
    Durand DJ; Gordon Green B; O'Connell JF; Grant SK
    Arch Biochem Biophys; 1999 Jul; 367(2):297-302. PubMed ID: 10395747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of substrate analogue inhibitors of peptide deformylase.
    Meinnel T; Patiny L; Ragusa S; Blanquet S
    Biochemistry; 1999 Apr; 38(14):4287-95. PubMed ID: 10194346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design of a macrocyclic inhibitor for peptide deformylase.
    Hu X; Nguyen KT; Verlinde CL; Hol WG; Pei D
    J Med Chem; 2003 Aug; 46(18):3771-4. PubMed ID: 12930137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of substrate specificity for peptide deformylase through the screening of a combinatorial peptide library.
    Hu YJ; Wei Y; Zhou Y; Rajagopalan PT; Pei D
    Biochemistry; 1999 Jan; 38(2):643-50. PubMed ID: 9888804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron center, substrate recognition and mechanism of peptide deformylase.
    Becker A; Schlichting I; Kabsch W; Groche D; Schultz S; Wagner AF
    Nat Struct Biol; 1998 Dec; 5(12):1053-8. PubMed ID: 9846875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approaches to antimicrobial therapy: peptide deformylase.
    Waller AS; Clements JM
    Curr Opin Drug Discov Devel; 2002 Sep; 5(5):785-92. PubMed ID: 12630299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxamic acids as potent inhibitors of Fe(II) and Mn(II) E. coli methionine aminopeptidase: biological activities and X-ray structures of oxazole hydroxamate-EcMetAP-Mn complexes.
    Huguet F; Melet A; Alves de Sousa R; Lieutaud A; Chevalier J; Maigre L; Deschamps P; Tomas A; Leulliot N; Pages JM; Artaud I
    ChemMedChem; 2012 Jun; 7(6):1020-30. PubMed ID: 22489069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide deformylase as an antibacterial drug target: assays for detection of its inhibition in Escherichia coli cell homogenates and intact cells.
    Apfel CM; Evers S; Hubschwerlen C; Pirson W; Page MG; Keck W
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1053-7. PubMed ID: 11257015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous spectrophotometric assay of peptide deformylase.
    Wei Y; Pei D
    Anal Biochem; 1997 Jul; 250(1):29-34. PubMed ID: 9234895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the Escherichia coli peptide deformylase.
    Chan MK; Gong W; Rajagopalan PT; Hao B; Tsai CM; Pei D
    Biochemistry; 1997 Nov; 36(45):13904-9. PubMed ID: 9374869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an eukaryotic peptide deformylase from Plasmodium falciparum.
    Bracchi-Ricard V; Nguyen KT; Zhou Y; Rajagopalan PT; Chakrabarti D; Pei D
    Arch Biochem Biophys; 2001 Dec; 396(2):162-70. PubMed ID: 11747293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of peptide deformylase activity by metal cations.
    Ragusa S; Blanquet S; Meinnel T
    J Mol Biol; 1998 Jul; 280(3):515-23. PubMed ID: 9665853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.